Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials

Kazumasa Saigoh,1 Takao Takeshima,2 Masami Nakai,3 Yoshiyuki Shibasaki,4 Miki Ishida,5 Xiaoping Ning,6 Steve Barash,6 Yuki Isogai,4 Nobuyuki Koga7 1Department of Neurology, Kindai University School of Medicine, Osaka, Japan; 2Headache Center, Department of Neurology, Tominaga Hospital, Osaka, Japan;...

Full description

Bibliographic Details
Main Authors: Saigoh K, Takeshima T, Nakai M, Shibasaki Y, Ishida M, Ning X, Barash S, Isogai Y, Koga N
Format: Article
Language:English
Published: Dove Medical Press 2023-04-01
Series:Journal of Pain Research
Subjects:
calcitonin gene-related peptide
chronic migraine
fremanezumab
japanese
Online Access:https://www.dovepress.com/fremanezumab-for-chronic-migraine-prevention-in-japanese-patients-subg-peer-reviewed-fulltext-article-JPR

Internet

https://www.dovepress.com/fremanezumab-for-chronic-migraine-prevention-in-japanese-patients-subg-peer-reviewed-fulltext-article-JPR

Similar Items